Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Active, not recruiting · NCT03435952 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, urinary system disorder | Active, not recruiting | Phase 1 | 2026-04-16 | NCT03435952 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioMed Valley Discoveries, Inc | 6 |
| M.D. Anderson Cancer Center | 1145 |
| Merck Sharp & Dohme LLC | 650 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |